Work

CNS activity of poziotinib in NSCLC with exon 20 insertion mutations.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.9093

Authors: Xiuning Le, Marina Chiara Garassino, Robin Cornelissen, Mark A. Socinski, Nishan Tchekmedyian, Julian R. Molina, Christina S Baik, Sharon Leu, Lyndah Dreiling, Francois M. Lebel, Jeffrey Melson Clarke

Institutions: The University of Texas MD Anderson Cancer Center, Erasmus MC, AdventHealth Orlando, Mayo Clinic, Seattle Cancer Care Alliance, Spectrum Pharmaceuticals (United States), Duke Medical Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Spectrum Pharmaceuticals

OpenAlex ID: W3172399401

Cites:

Cited by: 8

Related to: 10